February
Thursday 22 March 2018 photo 18/45
|
Hypertrophic cardiomyopathy guidelines 2017: >> http://ase.cloudz.pw/download?file=hypertrophic+cardiomyopathy+guidelines+2017 << (Download)
Hypertrophic cardiomyopathy guidelines 2017: >> http://ase.cloudz.pw/read?file=hypertrophic+cardiomyopathy+guidelines+2017 << (Read Online)
Persistent vital sign abnormalities. HCM indicates hypertrophic cardiomyopathy; HF, heart failure; ICD, implantable cardioverter-defibrillator; LV, left ventricular; SVT, supraventricular tachy- cardia; and VT, ventricular tachycardia. Shen W-K, et al. 2017 ACC/AHA/HRS Syncope Guideline: Executive Summary e227
2/14/2017. 1. Hypertrophic. Cardiomyopathy (HCM). William K. Freeman, MD, FACC, FASE. Diagnosis and Management: Role of Echocardiography. DISCLOSURES. Relevant Financial Relationship(s). None JACC 2011; 58: e212 ACC/AHA Guidelines. Hypertrophic Cardiomyopathy. Echocardiographic Diagnosis.
and preferences. 6. Specific risk assessment for sudden death is warranted in patients with cardiomyopathies with important specific considerations in patients with hypertrophic cardiomyopathy, sarcoidosis, arrhythmogenic cardiomyopathy and neuromuscular disease. 7. This is the first guideline to include value statements
11 Feb 2015 Hypertrophic cardiomyopathy, the most common genetic cardiac disease, is present in 1 out of 500 individuals regardless of race or gender, with the . 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of
Compiled consensus on the most important diagnostic modalities and genetic testing tools for the treatment of hypertrophic cardiomyopathy (HCM).
30 Oct 2017 October 30, 2017—The 2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac and updates the SCD prevention recommendations in the 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy.
25 Nov 2016 This standard of practice document briefly outlines the current approach to the diagnosis and management of hypertrophic cardiomyopathy (HCM). The supporting levels of evidence are reported in both the American Heart Association HCM guidelines(1) and the European Society of Cardiology.
29 Aug 2017 Barcelona, Spain – 29 Aug 2017: A large study conducted across North America, Europe, the Middle East and Asia has validated the ESC recommendations for predicting and preventing sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). The HCM-EVIDENCE study,
Hypertrophic Cardiomyopathy. ESC Clinical Practice Guidelines. Topic(s):. Cardiovascular Surgery. Myocardial Disease. Congenital Heart Disease and Pediatric Cardiology. Device Therapy. Interventional Cardiology. Ventricular Arrhythmias and Sudden Cardiac Death (SCD). Chronic Heart Failure. Epidemiology
1 Aug 2017 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Originally published March 9, 2017 . Hypertrophic Cardiomyopathy: Recommendation e36.
Annons
Visa toppen
Show footer